10-87933126-C-T
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000314.8(PTEN):c.367C>T(p.His123Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H123D) has been classified as Pathogenic.
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.367C>T | p.His123Tyr | missense_variant | 5/9 | ENST00000371953.8 | |
PTEN | NM_001304717.5 | c.886C>T | p.His296Tyr | missense_variant | 6/10 | ||
PTEN | NM_001304718.2 | c.-384C>T | 5_prime_UTR_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTEN | ENST00000371953.8 | c.367C>T | p.His123Tyr | missense_variant | 5/9 | 1 | NM_000314.8 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cowden syndrome 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Sep 27, 2023 | This variant is considered likely pathogenic. Functional studies indicate this variant impacts protein function [PMID: 9256433, 10555148, 16619501, 21475810]. This variant is expected to disrupt protein structure [Myriad internal data]. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | May 05, 2022 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Sep 14, 2023 | The PTEN c.367C>T (p.His123Tyr) variant has been reported in the published literature in an individual with breast cancer and a hematological malignancy (PMID: 26681312 (2015)). In a large-scale breast cancer association study, the variant was observed in an individual with breast cancer (PMID: 33471991 (2021), see also LOVD (http://databases.lovd.nl/shared/genes/PTEN)). Published functional studies suggest that this variant is detrimental to normal PTEN protein function (PMID: 21828076 (2011), 10555148 (1998), 9256433 (1997)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, this variant is classified as likely pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 03, 2023 | Published functional studies demonstrate a damaging effect: absent phosphatase activity (Myers et al., 1997; Lee et al., 1999; Rodriguez-Escudero et al., 2011); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in individual(s) with breast cancer (Evans et al., 2022); This variant is associated with the following publications: (PMID: 9256433, 16619501, 26681312, 10555148, 11448956, 21828076, 35426792, 19457929, 24475377, 32042934, 10772829) - |
PTEN hamartoma tumor syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 19, 2018 | In summary, this variant is a rare missense change that disrupts PTEN function. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. The histidine 123 residue is known to be critical for PTEN protein function. Other missense substitutions at this position (His123Asp, His123Arg, His123Gln) also disrupt PTEN function and have been reported in individuals affected with Cowden syndrome (PMID: 11918710, 9259288, 21291452). This variant falls in the conserved P-loop in the active site of the PTEN protein (PMID: 10555148). Multiple experimental studies have shown that this variant abolishes PTEN kinase activity, and leads to cell proliferation, anchorage-independent growth, and loss of cell cycle progression inhibition (PMID: 21828076, 10555148, 16619501, 10772829, 9256433). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in the germline of individuals with a PTEN-related disease. ClinVar contains an entry for this variant (Variation ID: 189486). This sequence change replaces histidine with tyrosine at codon 123 of the PTEN protein (p.His123Tyr). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and tyrosine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at